Adiponectin versus Bevacizumab in Decreasing Corneal Neovascularization

To compare the effect of adiponectin versus bevacizumab on reducing corneal neovascularization
This study was performed on 40 eyes of 20 New Zealand Albino male rabbits. Corneal neovascularization was induced by a 7-0 silk suture 2mm long and 1 mm away from the limbus. Rabbits were randomly divided into two groups of ten. In the first group, adiponectin eye drop and artificial tears were administered in the right and left eyes, respectively. In the second group, adiponectin eye drop was applied in the right eye and bevacizumab eye drop was used in the left eye for 14 days. The rabbits were examined regularly. Imaging was performed at each visit. The area of corneal vascularization and the length of vessels were measured and compared.
At the end of 14 days, the average length of vessels in the rabbits treated with adiponectin decreased from 2.12 ± 0.32 mm to 0.89 ± 0.46 mm, (57.68 ± 19.98% decrease ;1.24 ± 0.51mm) (P The results of this study suggest that adiponectin can potentially decrease youn corneal neovascularization. Its effect seems to be at least comparable to bevacizumab.